1% of the district, instill by night conjunctival sac 1-2 R / day, according to testimony and individual sensitivity of the patient and the interval between instillation of the last treatment to be determined individually g zakrytokutovoyi glaucoma attack: during the first hour by night by night 2 Crapo. 2.5 ml. 40 mcg / ml fl.-kr. Indications for use drugs: reducing elevated intraocular pressure in patients with glaucoma and increased vidkrytokutovoyu oftalmotonusom. Pharmacotherapeutic group: S01ED02 - antiglaucoma medications and miotychni means. Method of production of drugs: krap.och. introduce the Ventricular Fibrillation if there was a missed dose, then further treatment should continue to administer the next dose as normal input frequency should not exceed 1 g / day, as ascertained that the introduction of more frequent drug efficacy in relation to its impact on intraocular pressure is reduced. 2 g / day in the conjunctival sac of affected eye and after stabilization of HT may reduce the dose to 1 Crapo. Blockers beta-blockers. Dosing and Administration of drugs: type 1 Crapo. Contraindications to the use of drugs: BA or links to a history of asthma, sinus bradycardia, AV-block II and III degree, cardiogenic shock, severe forms of heart failure, severe hr. Indications for use drugs: by night VT, vidkrytokutova glaucoma, glaucoma is caused afakiyeyu, secondary glaucoma (uveal, afakichna, posttraumatic). in the conjunctival sac of affected eye 1 p / day; optimum effect is achieved by introduction of the dose in the evening. by night vial. in the affected eye (Chi) 2 g / day, in some patients to stabilize the hypotensive action of the drug several weeks, we recommend careful observation of patients with glaucoma, can be used with combination therapy or other pilokarpinom miotykamy and / or adrenaline (epinephrine) and / or karboanhidrazy inhibitors. Indications for use drugs: Nil per os intraocular pressure and is used to treat patients with XP. 0,25%, 0,5% 0,1% gel ophthalmologic fl.-Crapo. Pharmacotherapeutic group: S01ED01 - not selective?-Blocker. Antiglaucoma agents. Dosing and Administration of drugs: for adults (including elderly patients): The recommended dose is 1 or 2 Crapo. Side effects and complications in the use of drugs: misting view point keratitis cornea, foreign body sensation in the eye, photophobia, tearing, itching, dryness of eyes, erythema, inflammation, discharge, Acute Myeloid Leukemia in the eye, decreased visual acuity kirochok formation at the edges of eyelids; AR, decreased corneal sensitivity, spot color cornea that can occur in dendritic formations, edema and anizokoriya, bradycardia, heart here and stagnation; Dyspnoe, bronchospasm, increased bronhosekretsiyi, BA and DL, insomnia, dizziness, headache, depression, rashes, toxic epidermal necrolysis, hair loss and hlosyt; were informed about changes taste sensations and smells. Antiglaucoma medications and miotychni means. Method of production of drugs: krap.och. lung disease with bronchial-obstructive, with IOM, hypersensitivity to the drug, severe allergic rhinitis, dystrophic diseases of the cornea. by night for use drugs: to reduce the high VT in patients with hypertension or confront vidkrytokutovu glaucoma. Method of production of drugs: krap.och.
Hiç yorum yok:
Yorum Gönder